Construction of a Nomogram-Based Prediction Model for the Risk of Diabetic Kidney Disease in T2DM

References

• Guo L. Diabetes map of China. Beijing: National Center for Gerontology; 2022. Available from: https://class.medlive.cn/class/live/show/73315. Accessed 24 December 2022.
   Google Scholar
• American Diabetes Association Professional Practice Committee, American Diabetes Association Professional Practice Committee. 11. chronic kidney disease and risk management: standards of medical care in diabetes-2022. Diabetes Care. 2022;45:S175–S184. doi:10.2337/dc22-S011
   PubMedGoogle Scholar
• Zhang XX, Kong J, Yun K. Prevalence of diabetic nephropathy among patients with type 2 diabetes mellitus in China: a meta-analysis of observational studies. J Diabetes Res. 2020;2020:2315607. doi:10.1155/2020/2315607
   PubMed Web of Science ®Google Scholar
• ElSayed NA, Aleppo G, Aroda VR, et al. 2. Classification and diagnosis of diabetes: standards of care in diabetes-2023. Diabetes Care. 2023;46:S19–S40. doi:10.2337/dc23-S002
   PubMed Web of Science ®Google Scholar
• Qin Z, Zhou K, Li Y, et al. The atherogenic index of plasma plays an important role in predicting the prognosis of type 2 diabetic subjects undergoing percutaneous coronary intervention: results from an observational cohort study in China. Cardiovasc Diabetol. 2020;19:23. doi:10.1186/s12933-020-0989-8
   PubMed Web of Science ®Google Scholar
• Yue S, Li S, Huang X, et al. Construction and validation of a risk prediction model for acute kidney injury in patients suffering from septic shock. Dis Markers. 2022;2022:9367873.
   PubMed Web of Science ®Google Scholar
• Wang J, Wang Y, Li Y, et al. High normal urinary albumin-creatinine ratio is associated with hypertension, type 2 diabetes mellitus, HTN with T2DM, dyslipidemia, and cardiovascular diseases in the Chinese population: a report from the REACTION study. Front Endocrinol. 2022;13:864562. doi:10.3389/fendo.2022.864562
   PubMed Web of Science ®Google Scholar
• Triantafylidis LK, Hawley CE, Fagbote C, et al. A pilot study embedding clinical pharmacists within an interprofessional nephrology clinic for the initiation and monitoring of empagliflozin in diabetic kidney disease. J Pharm Pract. 2021;34(3):428–437. doi:10.1177/0897190019876499
   PubMed Web of Science ®Google Scholar
• Trakarnvanich T, Satirapoj B, Suraamornkul S, et al. Effect of Dipeptidyl Peptidase-4 (DPP-4) inhibition on biomarkers of kidney injury and vascular calcification in diabetic kidney disease: a randomized controlled trial. J Diabetes Res. 2021;2021:7382620. doi:10.1155/2021/7382620
   PubMedGoogle Scholar
• Yamada S, Tanabe J, Ogura Y, et al. Renoprotective effect of GLP-1 receptor agonist, liraglutide, in early-phase diabetic kidney disease in spontaneously diabetic torii fatty rats. Clin Exp Nephrol. 2021;25:365–375.
   PubMed Web of Science ®Google Scholar
• Leng W, Wu M, Pan H, et al. The SGLT2 inhibitor dapagliflozin attenuates the activity of ROS-NLRP3 inflammasome axis in steatohepatitis with diabetes mellitus. Ann Transl Med. 2019;7(18):429. doi:10.21037/atm.2019.09.03
   PubMed Web of Science ®Google Scholar
• Liljedahl L, Pedersen MH, McGuire JN, et al. The impact of the glucagon-like peptide 1 receptor agonist liraglutide on the streptozotocin-induced diabetic mouse kidney proteome. Physiol Rep. 2019;7(4):e13994. doi:10.14814/phy2.13994
   PubMed Web of Science ®Google Scholar
• Roy S, Schweiker-Kahn O, Jafry B, et al. Risk factors and comorbidities associated with diabetic kidney disease. J Prim Care Community Health. 2021;12:21501327211048556. doi:10.1177/21501327211048556
   Web of Science ®Google Scholar
• Bahadoran Z, Mirmiran P, Kashfi K, et al. Hyperuricemia-induced endothelial insulin resistance: the nitric oxide connection. Pflugers Arch. 2022;474:83–98.
   PubMed Web of Science ®Google Scholar
• Liu S, Yuan Y, Zhou Y, et al. Phloretin attenuates hyperuricemia-induced endothelial dysfunction through co-inhibiting inflammation and GLUT9-mediated uric acid uptake. J Cell Mol Med. 2017;21:2553–2562. doi:10.1111/jcmm.13176
   PubMed Web of Science ®Google Scholar
• Zhao Z, Zhao Y, Zhang Y, et al. Gout-induced endothelial impairment: the role of SREBP2 transactivation of YAP. FASEB J. 2021;35:e21613. doi:10.1096/fj.202100337R
   PubMed Web of Science ®Google Scholar
• Sasso FC, Pafundi PC, Gelso A, et al. Relationship between albuminuric CKD and diabetic retinopathy in a real-world setting of type 2 diabetes: findings from no blind study. Nutr Metab Cardiovasc Dis. 2019;29:923–930. doi:10.1016/j.numecd.2019.05.065
   PubMed Web of Science ®Google Scholar
• Liu Z, Li X, Wang Y, et al. The concordance and discordance of diabetic kidney disease and retinopathy in patients with type 2 diabetes mellitus: a cross-sectional study of 26,809 patients from 5 primary hospitals in China. Front Endocrinol. 2023;14:1133290. doi:10.3389/fendo.2023.1133290
   PubMed Web of Science ®Google Scholar
• Jiang S, Quan DV, Sung JH, et al. Cigarette smoke inhalation aggravates diabetic kidney injury in rats. Toxicol Res. 2019;8(6):964–971. doi:10.1039/c9tx00201d
   Web of Science ®Google Scholar
• Han Q, Wang S, Zhang J, et al. The association between cigarette smoking and diabetic nephropathy in Chinese male patients. Acta Diabetol. 2018;55(11):1131–1141. doi:10.1007/s00592-018-1197-9
   PubMed Web of Science ®Google Scholar
• Talukder MA, Johnson WM, Varadharaj S, et al. Chronic cigarette smoking causes hypertension, increased oxidative stress, impaired NO bioavailability, endothelial dysfunction, and cardiac remodeling in mice. Am J Physiol Heart Circulatory Physiol. 2011;300:H388–H396. doi:10.1152/ajpheart.00868.2010
   PubMed Web of Science ®Google Scholar
• Shigidi MM, Karrar WN. Risk factors associated with the development of diabetic kidney disease in Sudanese patients with type 2 diabetes mellitus: a case-control study. Diabetes Metab Syndr. 2021;15(6):102320. doi:10.1016/j.dsx.2021.102320
   PubMed Web of Science ®Google Scholar
• Jiang W, Wang J, Shen X, et al. Establishment and validation of a risk prediction model for early diabetic kidney disease based on a systematic review and meta-analysis of 20 cohorts. Diabetes Care. 2020;43(4):925–933. doi:10.2337/dc19-1897
   PubMed Web of Science ®Google Scholar
• Tu X, Luo N, Lv Y, et al. Prognostic evaluation model of diabetic nephropathy patients. Ann Palliat Med. 2021;10(6):6867–6872. doi:10.21037/apm-21-1454
   PubMed Web of Science ®Google Scholar
• Zhang W, Du J, Dong H, et al. Obesity metabolic phenotypes and unplanned readmission risk in diabetic kidney disease: an observational study from the nationwide readmission database. Arch Med Res. 2023;54(6):102840. doi:10.1016/j.arcmed.2023.102840
   PubMed Web of Science ®Google Scholar
• Shi S, Ni L, Tian Y, et al. Association of obesity indices with diabetic kidney disease and diabetic retinopathy in type 2 diabetes: a real-world study. J Diabetes Res. 2023;2023:3819830. doi:10.1155/2023/3819830
   PubMed Web of Science ®Google Scholar
• Ahlqvist E, Prasad RB, Groop L. Subtypes of type 2 diabetes determined from clinical parameters. Diabetes. 2020;69(10):2086–2093. doi:10.2337/dbi20-0001
   PubMed Web of Science ®Google Scholar
• Jawa A, Kcomt J, Fonseca VA. Diabetic nephropathy and retinopathy. Med Clin North Am. 2004;88(4):1001–36, xi. doi:10.1016/j.mcna.2004.04.012
   PubMed Web of Science ®Google Scholar
• Zhang B, Wan Y, Zhou X, et al. Characteristics of serum metabolites and gut microbiota in diabetic kidney disease. Front Pharmacol. 2022;13:872988. doi:10.3389/fphar.2022.872988
   PubMed Web of Science ®Google Scholar
• Gong L, Wang C, Ning G, et al. High concentrations of triglycerides are associated with diabetic kidney disease in new-onset type 2 diabetes in China: findings from the China cardiometabolic disease and cancer cohort (4c) study. Diabetes Obesity Metab. 2021;23:2551–2560. doi:10.1111/dom.14502
   PubMed Web of Science ®Google Scholar
• Tang C, Deng X, Qu J, et al. Fenofibrate attenuates renal tubular cell apoptosis by up-regulating MCAD in diabetic kidney disease. Drug Des Devel Ther. 2023;17:1503–1514. doi:10.2147/DDDT.S405266
   PubMed Web of Science ®Google Scholar
• Wang C, Wang L, Liang K, et al. Poor control of plasma triglycerides is associated with early decline of estimated glomerular filtration rates in new-onset type 2 diabetes in china: results from a 3-year follow-up study. J Diabetes Res. 2020;2020:3613041. doi:10.1155/2020/3613041
   PubMed Web of Science ®Google Scholar
• Nitta K, Hayashi T, Uchida K, et al. Serum cystatin C concentration as a marker of glomerular filtration rate in patients with various renal diseases. Intern Med. 2002;41:931–935. doi:10.2169/internalmedicine.41.931
   PubMed Web of Science ®Google Scholar
• Trutin I, Bajic Z, Turudic D, et al. Cystatin C, renal resistance index, and kidney injury molecule-1 are potential early predictors of diabetic kidney disease in children with type 1 diabetes. Front Pediatr. 2022;10:962048. doi:10.3389/fped.2022.962048
   PubMed Web of Science ®Google Scholar
• Srivastava SP, Hedayat AF, Kanasaki K, et al. microRNA crosstalk influences epithelial-to-mesenchymal, endothelial-to-mesenchymal, and macrophage-to-mesenchymal transitions in the kidney. Front Pharmacol. 2019;10:904. doi:10.3389/fphar.2019.00904
   PubMed Web of Science ®Google Scholar
• Srivastava SP, Koya D, Kanasaki K. MicroRNAs in kidney fibrosis and diabetic nephropathy: roles on EMT and EndMT. Biomed Res Int. 2013;2013:125469. doi:10.1155/2013/125469
   PubMed Web of Science ®Google Scholar
• Hua W, Ten Dijke P, Kostidis S, et al. TGFβ-induced metabolic reprogramming during epithelial-to-mesenchymal transition in cancer. Cell Mol Life Sci. 2020;77(11):2103–2123. doi:10.1007/s00018-019-03398-6
   PubMed Web of Science ®Google Scholar
• Felício JS, de Rider Britto HA, Cortez PC, et al. Association between 25(OH)Vitamin D, HbA1c and albuminuria in diabetes mellitus: data from a population-based study (VIDAMAZON). Front Endocrinol. 2021;12:723502. doi:10.3389/fendo.2021.723502
   PubMed Web of Science ®Google Scholar
• Abasheva D, Dolcet-Negre MM, Fernández-Seara MA, et al. Association between circulating levels of 25-Hydroxyvitamin D(3) and Matrix Metalloproteinase-10 (MMP-10) in patients with type 2 diabetes. Nutrients. 2022;14(17):3484. doi:10.3390/nu14173484
   PubMed Web of Science ®Google Scholar
• Souza CS, Deluque AL, Oliveira BM, et al. Vitamin D deficiency contributes to the diabetic kidney disease progression via increase ZEB1/ZEB2 expressions. Nutr Diabetes. 2023;13(1):9. doi:10.1038/s41387-023-00238-2
   PubMed Web of Science ®Google Scholar
• Wang Y, Quan F, Cao Q, et al. Quercetin alleviates acute kidney injury by inhibiting ferroptosis. J Adv Res. 2021;28:231–243. doi:10.1016/j.jare.2020.07.007
   PubMed Web of Science ®Google Scholar